The ROP16III-dependent early immune response determines the sub-acute CNS immune response and type III Toxoplasma gondii survival
S. Tuladhar, A. Koshy, J. A. Kochanowsky, A. Bhaskara, Y. Ghotmi
This study shows that the type III Toxoplasma gondii strain uses ROP16III to modulate early immune responses, which influences sub-acute CNS immune responses and parasite survival.
bioRxiv · May 21, 2019Microbiology